A major meta-analysis published earlier this year that questioned the empirical evidence for supervised drug consumption sites has been retracted by the International Journal of Drug Policy.
Supervised consumption sites (also known as safe injection sites) have gained traction across several US cities, including New York City, Philadelphia, and San Francisco, in response to the opioid epidemic. These sites, which already exist in Canada, Europe, and Australia, create a space where people can use drugs with sterile injection equipment and the supervision of trained staff, who are ready with the opioid overdose antidote naloxone if anything goes wrong. The sites may also link people to addiction treatment on request.
The idea: While in an ideal world, no one would use dangerous and potentially deadly drugs, many people do. So it’s better to give these people a space where they can use drugs with some sort of supervision. It’s a harm reduction approach.
[For more on this story by German Lopez, go to https://www.vox.com/science-an...ite-study-retraction]
Comments (0)